OncoSec

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OncoSec and other ETFs, options, and stocks.

About ONCS

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. 

CEO
Robert H. Arch
CEORobert H. Arch
Employees
41
Employees41
Headquarters
Pennington, New Jersey
HeadquartersPennington, New Jersey
Founded
2008
Founded2008
Employees
41
Employees41

ONCS Key Statistics

Market cap
6.90M
Market cap6.90M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.23M
Average volume3.23M
High today
$2.58
High today$2.58
Low today
$2.28
Low today$2.28
Open price
$2.53
Open price$2.53
Volume
164.72K
Volume164.72K
52 Week high
$34.76
52 Week high$34.76
52 Week low
$2.28
52 Week low$2.28

ONCS Earnings

-$6.38
-$4.25
-$2.13
-$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
per share
Estimated per share
Actual
Expected Dec 14, After Hours
ActualExpected Dec 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.